Cost-effectiveness of rosuvastatin versus atorvastatin, simvastatin, and pravastatin from a Canadian health care perspective

被引：0
|
作者：
Aosta-Scharplatz, M. [1 ]
Beamer, B. [2 ]
Frial, T. [2 ]
Gandhi, S. K. [3 ]
机构：
[1] AstraZeneca, Sodertalje, Sweden
[2] AstraZeneca, Mississauga, ON, Canada
[3] AstraZeneca, Wilmington, DE USA
来源：
VALUE IN HEALTH | 2007年 / 10卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A221 / A221
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness analysis of rosuvastatin versus atorvastatin, simvastatin, and pravastatin from a Canadian health system perspective
    Costa-Scharplatz, Madlaina
    Ramanathan, Krishnan
    Frial, Tony
    Bearner, Bruce
    Gandhi, Sanjay
    CLINICAL THERAPEUTICS, 2008, 30 (07) : 1345 - 1357
  • [2] Cost-effectiveness analysis of rosuvastatin compared to atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastatin
    Benner, JS
    Smith, TW
    Klingman, D
    Tierce, JC
    Mullins, CD
    Pethick, N
    O'Donnell, J
    VALUE IN HEALTH, 2004, 7 (03) : 323 - 323
  • [3] Comparison of Cost-Effectiveness, Safety, and Efficacy of Rosuvastatin Versus Atorvastatin, Pravastatin, and Simvastatin in Dyslipidemic Diabetic Patients With or Without Metabolic Syndrome
    Bener, Abdulbari
    Dogan, Muzeyyen
    Barakat, Lolwa
    Al-Hamaq, Abdulla O. A. A.
    JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH, 2014, 5 (03): : 180 - 187
  • [4] COST-EFFECTIVENESS OF ATORVASTATIN VERSUS SIMVASTATIN IN PREVENTION OF CARDIOVASCULAR EVENTS FROM A THAILAND SOCIETAL PERSPECTIVE
    Sukonthasarn, A.
    Thongtang, N.
    Ektare, V
    Du, F.
    Brizuela, G.
    Rustagi, S.
    Gao, X.
    VALUE IN HEALTH, 2021, 24 : S70 - S70
  • [5] Cost-effectiveness of rosuvastatin versus simvastatin, atorvastatin and pitavastatin in patients with high and very high cardiovascular risk in Spain
    Cosin Sales, Juan
    Fuentes Jimenez, Francisco Jose
    Mantilla Morato, Teresa
    Ruiz, Emilio
    Becerra, Virginia
    Aceituno, Susana
    Giovanna Ferrario, Maria
    Lizan, Luis
    Gracia, Alfredo
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2015, 27 (05): : 228 - 238
  • [6] The cost-effectiveness of atorvastatin, rosuvastatin and simvastatin in treating patients to LDL-cholesterol targets
    Niskanen, L.
    Peura, P. K.
    Hallinen, T.
    Soini, E.
    Martikainen, J.
    EUROPEAN HEART JOURNAL, 2007, 28 : 860 - 860
  • [7] Cost-effectiveness of atorvastatin compared to simvastatin in the Netherlands
    Severens, JL
    Prins, MH
    Monteban, HC
    VALUE IN HEALTH, 2003, 6 (06) : 671 - 671
  • [8] Cost-effectiveness of rosuvastatin versus ezetimibe/simvastatin in managing dyslipidemic patients in Mexico
    Gomez Briseno, German
    Mino-Leon, Dolores
    CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (05) : 1075 - 1081
  • [9] Effectiveness and cost-effectiveness of rosuvastatin, atorvastatin, and simvastatin among high-risk patients in usual clinical practice
    Ohsfeldt, Robert L.
    Gandhi, Sanjay K.
    Fox, Kathleen M.
    Stacy, Thomas A.
    McKenney, James M.
    AMERICAN JOURNAL OF MANAGED CARE, 2006, 12 (15): : S412 - S423
  • [10] Cost-effectiveness of rosuvastatin compared with other statins from a managed care perspective
    Benner, JS
    Smith, TW
    Klingman, D
    Tierce, JC
    Mullins, CD
    Pethick, N
    O'Donnell, JC
    VALUE IN HEALTH, 2005, 8 (06) : 618 - 628
12345